Treatment of Ebola Virus Disease in Seizure
Seizures are a recognised complication of Ebola virus disease (EVD). They can arise from several distinct underlying causes — including hypoglycaemia, sepsis, Ebola viral meningoencephalitis, intracranial haemorrhage, and a pre-existing seizure disorder — making rapid identification of the precipitant clinically important before selecting the appropriate management pathway.
The structured approach involves intravenous anticonvulsant therapy, with agent selection and dosing sequence determined by patient age and clinical context. The protocol specifies primary and alternative agents, age-stratified loading and maintenance regimens, and the decision points between options.
References
Seizures can occur in EVD for a number of different reasons, including hypoglycaemia, sepsis, Ebola viral meningoencephalitis, intracranial haemorrhage and underlying seizure disorder, among others.
17+ years 10 mg/kg. Maximum dose 1 g IV.
12–17 years 20 mg/kg, maximum dose 1 g.
17+ years 20 mg/kg, maximum dose 2 g IV.
View source ↗